Literature DB >> 1725413

Endothelin-like immunoreactivity in the nervous system of invertebrates and fish.

Y Kasuya1, H Kobayashi, H Uemura.   

Abstract

There have been no reports on the distribution of immunoreactive endothelin (ir-ET) in lower vertebrates and invertebrates, except for our previous studies on the nereid Neanthes diversicolor and the earthworm Eisenia foetida. In the present study, we found ET-like immunoreactivity in five species of invertebrates and two species of fish with antiserum against synthetic endothelin-1 (ET-1). Immunoreactive perikarya and nerve fibers were observed in the central nervous system of the slug Limax marginatus, the freshwater snail Indoplanorbis exustus, and the mussel Mytilus edulis in mollusks, the field cricket Gryllus bimaculatus in insects, and the tube tunicate Ciona intestinalis in protochordates. In the medaka, Oryzias latipes, ir-ET was found in the hypothalamoneurohypophysial system, the caudal neurosecretory system, the gill, and the kidney. Immunoreactive cells were also found in the mucous gland of the slug and in the adenohypophysis of the lamprey, Lampetra japonica. The wide distribution of ET-like substances in invertebrates and fish provides evidence for the case that ET found in mammals has a long evolutionary history.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1725413     DOI: 10.1097/00005344-199100177-00133

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  2 in total

1.  ETB-type receptors mediate endothelin-stimulated contraction in the aortic vascular smooth muscle of the spiny dogfish shark, Squalus acanthias.

Authors:  D H Evans; M Gunderson; C Cegelis
Journal:  J Comp Physiol B       Date:  1996       Impact factor: 2.200

2.  Pharmacological characterization of endothelin receptors-mediated contraction in the mouse isolated proximal and distal colon.

Authors:  Humaira Khan; Robert J Naylor; Bishwa R Tuladhar
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.